IQVIA Holdings Inc.
Health
Performance
5.4
Risk
Sell
Buy
Curious about the Scores? Learn more.

IQVIA Holdings Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

02.07.2026
Shaky at first, now slowly moving toward steady ground.
30.06.2026
Signs of control returning. Still shaky, but not chaos.
26.06.2026
Slight bounce. Could be noise – or a comeback brewing.
20.08.2025
Climbing out. Risks fading, but not out of the woods.
IQV
IQVIA Holdings Inc.
206.26
-2.01%
5.4
Sell
Buy
IQVIA Holdings Inc.

IQVIA Holdings Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does IQVIA Holdings Inc. do? Business model and key facts

Get the full picture of IQVIA Holdings Inc.: what it builds, where it operates, and how it makes money.

IQVIA Holdings Inc. Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 93000

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

shop
Company facts
Ari Bousbib
CEO
93000
Employees worldwide
shop
Performance
28.41%
Last 12 months
-14.66%
Last 5 years
shop
Growth
$16.31B
Revenue year
$1.36B
Net income
shop
Valuation
$34.42B
Market Cap
28.50
Price/Earnings Ratio

Stocks related to IQVIA Holdings Inc.

Selected based on industry alignment and relative market positioning.

A
Agilent Technologies, Inc.
131.46
-3.41%
3.9
Sell
Buy
Agilent Technologies, Inc.
NTRA
Natera, Inc.
271.39
+0.58%
5.9
Sell
Buy
Natera, Inc.
IDXX
IDEXX Laboratories, Inc.
567.44
-1.50%
4.7
Sell
Buy
IDEXX Laboratories, Inc.
ILMN
Illumina, Inc.
186.65
-1.89%
5.2
Sell
Buy
Illumina, Inc.
MTD
Mettler-Toledo International Inc.
1,310.02
-1.88%
5.2
Sell
Buy
Mettler-Toledo International Inc.

Events and news impacting IQVIA Holdings Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

IQVIA Holdings Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.